Laureate Pharma Gets $20 Million

Laureate Pharma Inc. obtained $20 million via debt and equity financing. The Princeton, N.J.-based contract development and manufacturing organization plans to invest the funds, over the next three years, to add scientific services it offers and to expand its cGMp production capacity. Laureate Pharma is backed by San Francisco, Calif.-based Saints Capital LLC.

North AmericaUSBriefs